COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78 | -14.3% | 20,914 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $91 | -37.7% | 21,243 | -0.6% | 0.00% | -33.3% |
| Q1 2023 | $146 | -14.1% | 21,365 | -0.3% | 0.01% | -14.3% |
| Q4 2022 | $170 | -99.9% | 21,440 | -16.9% | 0.01% | -30.0% |
| Q3 2022 | $248,000 | +5.1% | 25,793 | -20.8% | 0.01% | +42.9% |
| Q2 2022 | $236,000 | -43.8% | 32,553 | +0.2% | 0.01% | -30.0% |
| Q1 2022 | $420,000 | -29.4% | 32,498 | -12.9% | 0.01% | -16.7% |
| Q4 2021 | $595,000 | -0.3% | 37,307 | +0.5% | 0.01% | -7.7% |
| Q3 2021 | $597,000 | +11.4% | 37,128 | -4.1% | 0.01% | +30.0% |
| Q2 2021 | $536,000 | +0.2% | 38,728 | +5.7% | 0.01% | -9.1% |
| Q1 2021 | $535,000 | +73.1% | 36,628 | +106.1% | 0.01% | +83.3% |
| Q4 2020 | $309,000 | – | 17,769 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |